Skip to content

145020.KQ

Hugel, Inc.

KOE · Healthcare · Biotechnology · KR

KRW 240,500.00
−2.04%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue479.6B425.1B373.0B319.7B281.7B
Cost of Revenue113.6B102.1B85.9B73.5B62.8B
Gross Profit366.0B323.0B287.2B246.2B218.9B
Operating Expenses
R&D Expense9.9B11.6B9.2B11.0B15.1B
SG&A Expense54.7B63.9B60.1B109.5B58.9B
General & Admin Expense4.7B5.4B5.8B6.7B5.3B
Selling & Marketing Expense50.0B58.4B54.3B61.2B53.6B
Other Expenses92.5B47.0B51.6B49.5B43.5B
Total Operating Expenses157.1B122.5B120.9B120.5B117.5B
Cost and Expenses270.7B223.5B206.8B194.0B180.3B
Operating Income (EBIT)208.9B200.5B166.2B125.7B101.4B
Non-Operating
Interest Income13.6B12.6B14.7B14.7B11.5B
Interest Expense1.1B1.1B1.2B2.9B3.1B
Net Interest Income12.6B11.5B13.6B14.7B8.4B
Other Non-Op Income/Expense11.1B(3.8B)(1.0B)7.6B(28.3B)
Non-Operating Income (excl Interest)3.0B(128.9M)7.9B25.2B
EBT (Pre-Tax Income)220.0B197.5B165.2B133.3B73.1B
Income Tax Expense56.7B49.8B22.0B35.6B9.2B
Bottom Line
Net Income158.0B140.9B135.8B93.1B57.3B
Earnings from Cont. Ops163.2B147.0B143.1B97.7B63.9B
Earnings from Discont. Ops(3.2B)
Bottom Line Net Income158.1B141.5B135.8B93.1B57.3B
Per Share
Basic EPS₩13,860₩13,061₩12,520₩8,217₩4,811
Diluted EPS₩13,260₩12,820₩12,042₩7,934₩4,743
Revenue Per Share₩37,759₩33,111₩33,975₩28,225₩23,636
Shares
Basic Shares Outstanding12.7M12.8M11.0M11.3M11.9M
Diluted Shares Outstanding12.7M12.8M11.3M11.7M12.1M
Profitability Metrics
EBITDA200.0B220.3B181.4B131.6B115.4B
D&A21.1B19.7B15.0B13.9B14.0B
EBIT178.9B200.5B166.4B117.7B101.4B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026